Publication date: Aug 01, 2023
With the rapid emergence and prevalence of SARS-CoV-2 worldwide, cases of COVID-19-associated nephropathy (COVAN) from collapsing focal segmental glomerulosclerosis (cFSGS) have been reported, and the associations between the two are actively being studied. Creating appropriate treatment guidelines for COVAN requires further understanding of the pathophysiology of this type of kidney injury. This case report outlines the case of a 77-year-old patient admitted to the hospital for COVID-19 infection with a subsequent renal biopsy indicating cFSGS, adding to the data exploring the relationship between COVID-19 infections, cFSGS and the associated risk factors. Current guidelines on the treatment of COVAN are similar to those of other causes of cFSGS but continue to have poor outcomes and resistance to treatments. Further research needs to be done on both the clinical assessment and pathophysiology of COVAN to provide timely and life-saving interventions.
| Concepts | Keywords |
|---|---|
| Devastating | collapsing fsgs |
| Glomerulosclerosis | covan |
| Hospital | covid-19 |
| Kidney | glomerulosclerosis |
| Timely | nephropathy |
| nephrotic | |
| sars-cov-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | focal segmental glomerulosclerosis |
| disease | VO | report |
| disease | MESH | infection |
| disease | MESH | causes |